Ignite Creation Date:
2025-12-24 @ 10:02 PM
Ignite Modification Date:
2026-01-22 @ 2:07 AM
Study NCT ID:
NCT05835635
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-11-07
First Post:
2023-03-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Switch From Oral Therapy to Long-acting Injectable Cabotegravir + Rilpivirine
Sponsor:
Pontificia Universidad Catolica de Chile
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
220817002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |